Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Survival of patients treated with intra-aortic balloon counterpulsation at a tertiary care center in Pakistan – patient characteristics and predictors of in-hospital mortality

Autor: Shafquat Azam, Dhakam Sajid, Kazmi Khawar A, Malik Numaan F, Kumar Haresh, Khan Sohail A, Jafary Fahim H, Hameed Aamir, Tai Javed, Nadeem Najaf

Publikováno v: BMC Cardiovascular Disorders, Vol 4, Iss 1, p 22 (2004)

Abstract Background Intra-aortic balloon counterpulsation (IABC) has an established role in the treatment of patients presenting with critical cardiac illnesses, including cardiogenic shock, refractory ischemia and for prophylaxis and treatment of co

Externí odkaz: https://doaj.org/article/e71df2c449a141aab6128d72fc809c34

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction.

Autor: Hayashi H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. hayashih@cgt.med.osaka-u.ac.jp., Sun J; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Yanagida Y; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Otera T; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Anges Inc., Tokyo, Japan., Tai JA; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Nishikawa T; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Yamashita K; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Daicel Co, Osaka, Japan., Sakaguchi N; Daicel Co, Osaka, Japan., Yoshida S; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Baba S; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Chang CY; Department of Gene and Stem Cell Regenerative Therapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Shimamura M; Department of Gene and Stem Cell Regenerative Therapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Okamoto S; Takara Bio Inc., Kusatsu, Shiga, Japan., Amaishi Y; Takara Bio Inc., Kusatsu, Shiga, Japan., Chono H; Takara Bio Inc., Kusatsu, Shiga, Japan., Mineno J; Takara Bio Inc., Kusatsu, Shiga, Japan., Rakugi H; Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Morishita R; Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Nakagami H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan.

Publikováno v: Scientific reports [Sci Rep] 2023 Aug 10; Vol. 13 (1), pp. 13033. Date of Electronic Publication: 2023 Aug 10.

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant.

Autor: Hayashi H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. hayashih@cgt.med.osaka-u.ac.jp., Sun J; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan., Yanagida Y; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan., Otera T; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.; Anges Inc., Tokyo, Japan., Sasai M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.; Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.; Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan., Chang CY; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan., Tai JA; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan., Nishikawa T; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan., Yamashita K; Department of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan.; Daicel Co., Osaka, Japan., Sakaguchi N; Daicel Co., Osaka, Japan., Yoshida S; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.; Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan., Baba S; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.; Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan., Shimamura M; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.; Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan., Okamoto S; Takara Bio Inc., Shiga, Japan., Amaishi Y; Takara Bio Inc., Shiga, Japan., Chono H; Takara Bio Inc., Shiga, Japan., Mineno J; Takara Bio Inc., Shiga, Japan., Rakugi H; Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan., Morishita R; Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Osaka, Japan., Yamamoto M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.; Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.; Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan., Nakagami H; Department of Health Development and Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.; Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan.

Publikováno v: Scientific reports [Sci Rep] 2022 Dec 03; Vol. 12 (1), pp. 20923. Date of Electronic Publication: 2022 Dec 03.

Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.

Autor: Kong SL; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Liu X; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Tan SJ; Clearbridge mFluidics Pte Ltd, Singapore, Singapore., Tai JA; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Phua LY; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Poh HM; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Yeo T; Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore., Chua YW; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Haw YX; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Ling WH; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore., Ng RCH; Division of Medical Oncology, National Cancer Center, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Tan TJ; Division of Medical Oncology, National Cancer Center, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Loh KWJ; Division of Medical Oncology, National Cancer Center, Singapore, Singapore., Tan DS; Division of Medical Oncology, National Cancer Center, Singapore, Singapore., Ng QS; Division of Medical Oncology, National Cancer Center, Singapore, Singapore., Ang MK; Division of Medical Oncology, National Cancer Center, Singapore, Singapore., Toh CK; Division of Medical Oncology, National Cancer Center, Singapore, Singapore., Lee YF; Biolidics Ltd, Singapore, Singapore., Lim CT; Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore., Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Hillmer AM; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Yap YS; Division of Medical Oncology, National Cancer Center, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Lim WT; Division of Medical Oncology, National Cancer Center, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.; IMCB-NCCS-MP Singapore OncoGenome Laboratory, Institute of Molecular and Cell Biology, Singapore, Singapore.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Jul 16; Vol. 11, pp. 698551. Date of Electronic Publication: 2021 Jul 16 (Print Publication: 2021).